Changchun BCHT Biotechnology Future Growth

Future criteria checks 5/6

Changchun BCHT Biotechnology is forecast to grow earnings and revenue by 25.5% and 21.1% per annum respectively. EPS is expected to grow by 24.8% per annum. Return on equity is forecast to be 17.2% in 3 years.

Key information

25.5%

Earnings growth rate

24.8%

EPS growth rate

Biotechs earnings growth	32.4%
Revenue growth rate	21.1%
Future return on equity	17.2%
Analyst coverage	Good
Last updated	23 May 2024

Recent future growth updates

No updates

Recent updates

Is Changchun BCHT Biotechnology (SHSE:688276) Using Too Much Debt?

Jun 19

Changchun BCHT Biotechnology Co. (SHSE:688276) Shares Slammed 25% But Getting In Cheap Might Be Difficult Regardless

Apr 16

We Think That There Are Issues Underlying Changchun BCHT Biotechnology's (SHSE:688276) Earnings

Mar 30

Earnings and Revenue Growth Forecasts

SHSE:688276 - Analysts future estimates and past financials data (CNY Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2026	3,491	1,120	N/A	965	7
12/31/2025	3,024	931	N/A	799	8
12/31/2024	2,474	710	N/A	552	4
3/31/2024	1,916	543	-249	252	N/A
12/31/2023	1,825	501	-215	255	N/A
9/30/2023	1,449	301	-260	254	N/A
6/30/2023	1,190	219	-308	141	N/A
3/31/2023	1,113	183	-185	117	N/A
12/31/2022	1,071	182	-251	40	N/A
9/30/2022	1,123	222	-126	74	N/A
6/30/2022	1,061	179	-301	101	N/A
3/31/2022	1,093	205	-414	138	N/A
12/31/2021	1,202	244	-493	140	N/A
9/30/2021	1,304	309	-486	141	N/A
6/30/2021	1,424	377	-280	230	N/A
3/31/2021	1,489	424	-189	191	N/A
12/31/2020	1,441	418	-127	209	N/A
12/31/2019	976	221	104	233	N/A
12/31/2018	1,019	128	89	270	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 688276's forecast earnings growth (25.5% per year) is above the savings rate (2.9%).

Earnings vs Market: 688276's earnings (25.5% per year) are forecast to grow faster than the CN market (22.1% per year).

High Growth Earnings: 688276's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 688276's revenue (21.1% per year) is forecast to grow faster than the CN market (13.6% per year).

High Growth Revenue: 688276's revenue (21.1% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 688276's Return on Equity is forecast to be low in 3 years time (17.2%).

Changchun BCHT Biotechnology Future Growth

Future criteria checks 5/6

Key information

Recent future growth updates

Recent updates

Changchun BCHT Biotechnology Co. to Report First Half, 2024 Results on Aug 16, 2024

Is Changchun BCHT Biotechnology (SHSE:688276) Using Too Much Debt?

First quarter 2024 earnings released: EPS: CN¥0.15 (vs CN¥0.04 in 1Q 2023)

Changchun BCHT Biotechnology Co. (SHSE:688276) Shares Slammed 25% But Getting In Cheap Might Be Difficult Regardless

We Think That There Are Issues Underlying Changchun BCHT Biotechnology's (SHSE:688276) Earnings

Changchun BCHT Biotechnology Co. to Report Q1, 2024 Results on Apr 20, 2024

Investor sentiment deteriorates as stock falls 15%

Changchun BCHT Biotechnology Co., Annual General Meeting, Apr 10, 2024

Full year 2023 earnings: EPS in line with expectations, revenues disappoint

Investor sentiment improves as stock rises 17%

First quarter 2023 earnings released: EPS: CN¥0.04 (vs CN¥0.04 in 1Q 2022)

Full year 2022 earnings: EPS and revenues miss analyst expectations

Less than half of directors are independent

Third quarter 2022 earnings released: EPS: CN¥0.32 (vs CN¥0.23 in 3Q 2021)

First quarter 2022 earnings: EPS and revenues miss analyst expectations

Investor sentiment deteriorated over the past week

Full year 2021 earnings: EPS and revenues miss analyst expectations

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

Earnings and Revenue Growth Forecasts

Analyst Future Growth Forecasts

Earnings per Share Growth Forecasts

Future Return on Equity

Discover growth companies